These samples need more evidence before they can be counted. This includes samples without a confirmed case/control role.
NP, Rectum, 257236323159_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 67; disease_duration_yr: 39.95; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS061
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517415
sample_title: NP, Rectum, 257236323159_1_2
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 67; disease_duration_yr: 39.95; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS061
NP, Ascending, 257236323159_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 67; disease_duration_yr: 39.95; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS062
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517416
sample_title: NP, Ascending, 257236323159_1_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 67; disease_duration_yr: 39.95; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS062
NP, Descending, 257236323159_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 67; disease_duration_yr: 39.95; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS062
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517417
sample_title: NP, Descending, 257236323159_1_4
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 67; disease_duration_yr: 39.95; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS062
NP, Rectum, 257236323159_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 67; disease_duration_yr: 39.95; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS062
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517418
sample_title: NP, Rectum, 257236323159_2_1
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 67; disease_duration_yr: 39.95; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS062
NP, Ascending, 257236323159_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 64; disease_duration_yr: 37.18; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS066
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517419
sample_title: NP, Ascending, 257236323159_2_2
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 64; disease_duration_yr: 37.18; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS066
NP, Descending, 257236323159_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 64; disease_duration_yr: 37.18; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS066
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517420
sample_title: NP, Descending, 257236323159_2_3
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 64; disease_duration_yr: 37.18; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS066
NP, Rectum, 257236323159_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 64; disease_duration_yr: 37.18; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS066
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517421
sample_title: NP, Rectum, 257236323159_2_4
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 27; age_at_inclusion: 64; disease_duration_yr: 37.18; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS066
NP, Rectum, 257236323160_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 41; age_at_inclusion: 54; disease_duration_yr: 12.49; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS050
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517422
sample_title: NP, Rectum, 257236323160_1_1
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 41; age_at_inclusion: 54; disease_duration_yr: 12.49; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS050
NP, Ascending, 257236323160_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 41; age_at_inclusion: 54; disease_duration_yr: 12.49; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS058
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517423
sample_title: NP, Ascending, 257236323160_1_4
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 41; age_at_inclusion: 54; disease_duration_yr: 12.49; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS058
NP, Descending, 257236323160_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 41; age_at_inclusion: 54; disease_duration_yr: 12.49; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS058
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517424
sample_title: NP, Descending, 257236323160_2_1
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 41; age_at_inclusion: 54; disease_duration_yr: 12.49; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS058
NP, Rectum, 257236323160_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS058
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517425
sample_title: NP, Rectum, 257236323160_2_2
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS058
NP, Ascending, 257236323160_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS061
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517426
sample_title: NP, Ascending, 257236323160_2_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS061
NP, Descending, 257236323160_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS061
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517427
sample_title: NP, Descending, 257236323160_2_4
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS061
NP, Rectum, 257236323161_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS044
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517428
sample_title: NP, Rectum, 257236323161_1_1
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS044
P, Transverse, 257236323161_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Transverse; patient_id: AS048
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517429
sample_title: P, Transverse, 257236323161_1_3
source_name: Transverse
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Transverse; patient_id: AS048
NP, Ascending, 257236323161_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS050
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517430
sample_title: NP, Ascending, 257236323161_2_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS050
NP, Descending, 257236323161_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS050
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517431
sample_title: NP, Descending, 257236323161_2_4
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 16; age_at_inclusion: 55; disease_duration_yr: 38.25; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS050
NP, Ascending, 257236324305_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 17; age_at_inclusion: 70; disease_duration_yr: 53.27; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS027
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517432
sample_title: NP, Ascending, 257236324305_1_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 17; age_at_inclusion: 70; disease_duration_yr: 53.27; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS027
NP, Descending, 257236324305_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 17; age_at_inclusion: 70; disease_duration_yr: 53.27; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS027
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517433
sample_title: NP, Descending, 257236324305_1_2
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 17; age_at_inclusion: 70; disease_duration_yr: 53.27; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS027
NP, Rectum, 257236324305_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 17; age_at_inclusion: 70; disease_duration_yr: 53.27; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS027
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517434
sample_title: NP, Rectum, 257236324305_1_3
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 17; age_at_inclusion: 70; disease_duration_yr: 53.27; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS027
NP, Ascending, 257236324305_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 17; age_at_inclusion: 70; disease_duration_yr: 53.27; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS036
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517435
sample_title: NP, Ascending, 257236324305_1_4
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 17; age_at_inclusion: 70; disease_duration_yr: 53.27; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS036
NP, Descending, 257236324305_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 46; age_at_inclusion: 62; disease_duration_yr: 16.29; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS036
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517436
sample_title: NP, Descending, 257236324305_2_1
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 46; age_at_inclusion: 62; disease_duration_yr: 16.29; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS036
NP, Rectum, 257236324305_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 46; age_at_inclusion: 62; disease_duration_yr: 16.29; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS036
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517437
sample_title: NP, Rectum, 257236324305_2_2
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 46; age_at_inclusion: 62; disease_duration_yr: 16.29; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS036
NP, Ascending, 257236324305_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 46; age_at_inclusion: 62; disease_duration_yr: 16.29; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS038
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517438
sample_title: NP, Ascending, 257236324305_2_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 46; age_at_inclusion: 62; disease_duration_yr: 16.29; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS038
NP, Descending, 257236324305_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 17; age_at_inclusion: 30; disease_duration_yr: 13.42; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS038
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517439
sample_title: NP, Descending, 257236324305_2_4
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 17; age_at_inclusion: 30; disease_duration_yr: 13.42; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS038
NP, Rectum, 257236324320_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 35; age_at_inclusion: 44; disease_duration_yr: 8.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS069
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517440
sample_title: NP, Rectum, 257236324320_1_1
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 35; age_at_inclusion: 44; disease_duration_yr: 8.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS069
NP, Ascending, 257236324320_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 35; age_at_inclusion: 44; disease_duration_yr: 8.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS081
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517441
sample_title: NP, Ascending, 257236324320_1_2
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 35; age_at_inclusion: 44; disease_duration_yr: 8.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS081
NP, Descending, 257236324320_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 35; age_at_inclusion: 44; disease_duration_yr: 8.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS081
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517442
sample_title: NP, Descending, 257236324320_1_3
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 35; age_at_inclusion: 44; disease_duration_yr: 8.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS081
NP, Rectum, 257236324320_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 27; age_at_inclusion: 46; disease_duration_yr: 19.59; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS081
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517443
sample_title: NP, Rectum, 257236324320_1_4
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 27; age_at_inclusion: 46; disease_duration_yr: 19.59; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS081
NP, Ascending, 257236324320_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 27; age_at_inclusion: 46; disease_duration_yr: 19.59; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS082
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517444
sample_title: NP, Ascending, 257236324320_2_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 27; age_at_inclusion: 46; disease_duration_yr: 19.59; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS082
NP, Descending, 257236324320_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 27; age_at_inclusion: 46; disease_duration_yr: 19.59; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS082
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517445
sample_title: NP, Descending, 257236324320_2_2
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 27; age_at_inclusion: 46; disease_duration_yr: 19.59; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS082
NP, Rectum, 257236324320_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: F; age_at_diagnosis: 34; age_at_inclusion: 42; disease_duration_yr: 8.44; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS082
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517446
sample_title: NP, Rectum, 257236324320_2_3
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: F; age_at_diagnosis: 34; age_at_inclusion: 42; disease_duration_yr: 8.44; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS082
NP, Ascending, 257236324320_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: F; age_at_diagnosis: 34; age_at_inclusion: 42; disease_duration_yr: 8.44; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS086
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517447
sample_title: NP, Ascending, 257236324320_2_4
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: F; age_at_diagnosis: 34; age_at_inclusion: 42; disease_duration_yr: 8.44; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS086
NP, Descending, 257236324321_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 34; age_at_inclusion: 42; disease_duration_yr: 8.44; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS086
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517448
sample_title: NP, Descending, 257236324321_1_1
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 34; age_at_inclusion: 42; disease_duration_yr: 8.44; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS086
NP, Rectum, 257236324321_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 34; age_at_inclusion: 42; disease_duration_yr: 8.44; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS086
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517449
sample_title: NP, Rectum, 257236324321_1_2
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 34; age_at_inclusion: 42; disease_duration_yr: 8.44; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS086
NP, Ascending, 257236324321_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 43; age_at_inclusion: 65; disease_duration_yr: 21.65; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS095
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517450
sample_title: NP, Ascending, 257236324321_1_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 43; age_at_inclusion: 65; disease_duration_yr: 21.65; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS095
NP, Sigmoid, 257236324321_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 43; age_at_inclusion: 65; disease_duration_yr: 21.65; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: AS095
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517451
sample_title: NP, Sigmoid, 257236324321_1_4
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 43; age_at_inclusion: 65; disease_duration_yr: 21.65; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: AS095
NP, Rectum, 257236324321_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 43; age_at_inclusion: 65; disease_duration_yr: 21.65; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS095
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517452
sample_title: NP, Rectum, 257236324321_2_1
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 43; age_at_inclusion: 65; disease_duration_yr: 21.65; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS095
NP, Ascending, 257236324321_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 10.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS096
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517453
sample_title: NP, Ascending, 257236324321_2_2
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 10.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS096
NP, Descending, 257236324321_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 10.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS096
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517454
sample_title: NP, Descending, 257236324321_2_3
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 10.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS096
NP, Rectum, 257236324321_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 10.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS096
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517455
sample_title: NP, Rectum, 257236324321_2_4
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 10.69; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS096
NP, Ascending, 257236324322_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 38; age_at_inclusion: 56; disease_duration_yr: 17.71; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS067
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517456
sample_title: NP, Ascending, 257236324322_1_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 38; age_at_inclusion: 56; disease_duration_yr: 17.71; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS067
NP, Descending, 257236324322_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 38; age_at_inclusion: 56; disease_duration_yr: 17.71; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS067
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517457
sample_title: NP, Descending, 257236324322_1_2
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 38; age_at_inclusion: 56; disease_duration_yr: 17.71; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS067
NP, Rectum, 257236324322_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 38; age_at_inclusion: 56; disease_duration_yr: 17.71; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS067
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517458
sample_title: NP, Rectum, 257236324322_1_3
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 38; age_at_inclusion: 56; disease_duration_yr: 17.71; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS067
NP, Ascending, 257236324322_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 11.14; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 1; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS068
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517459
sample_title: NP, Ascending, 257236324322_1_4
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 11.14; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 1; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS068
NP, Descending, 257236324322_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 11.14; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 1; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS068
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517460
sample_title: NP, Descending, 257236324322_2_1
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 11.14; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 1; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS068
NP, Rectum, 257236324322_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 11.14; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 1; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS068
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517461
sample_title: NP, Rectum, 257236324322_2_2
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 50; age_at_inclusion: 61; disease_duration_yr: 11.14; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 1; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS068
NP, Ascending, 257236324322_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 43; disease_duration_yr: 10.55; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS069
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517462
sample_title: NP, Ascending, 257236324322_2_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 43; disease_duration_yr: 10.55; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS069
NP, Descending, 257236324322_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 43; disease_duration_yr: 10.55; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS069
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517463
sample_title: NP, Descending, 257236324322_2_4
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 43; disease_duration_yr: 10.55; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS069
P, Rectum, 257236324323_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 43; disease_duration_yr: 10.55; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS041
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517464
sample_title: P, Rectum, 257236324323_1_1
source_name: Rectum
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 43; disease_duration_yr: 10.55; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS041
P, Rectum, 257236324323_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 55; disease_duration_yr: 28.81; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS041
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517465
sample_title: P, Rectum, 257236324323_1_2
source_name: Rectum
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 55; disease_duration_yr: 28.81; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS041
P, Transverse, 257236324323_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 55; disease_duration_yr: 28.81; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS042
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517466
sample_title: P, Transverse, 257236324323_1_3
source_name: Transverse
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 55; disease_duration_yr: 28.81; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS042
P, Descending, 257236324323_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 55; disease_duration_yr: 28.81; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS042
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517467
sample_title: P, Descending, 257236324323_1_4
source_name: Descending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 55; disease_duration_yr: 28.81; salazopyrine: 1; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS042
P, Sigmoid, 257236324323_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 31; age_at_inclusion: 54; disease_duration_yr: 22.85; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Sigmoid; patient_id: AS042
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517468
sample_title: P, Sigmoid, 257236324323_2_1
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 31; age_at_inclusion: 54; disease_duration_yr: 22.85; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Sigmoid; patient_id: AS042
P, Rectum, 257236324323_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 31; age_at_inclusion: 54; disease_duration_yr: 22.85; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS042
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517469
sample_title: P, Rectum, 257236324323_2_2
source_name: Rectum
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 31; age_at_inclusion: 54; disease_duration_yr: 22.85; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS042
NP, Ascending, 257236324323_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 31; age_at_inclusion: 54; disease_duration_yr: 22.85; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS044
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517470
sample_title: NP, Ascending, 257236324323_2_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 31; age_at_inclusion: 54; disease_duration_yr: 22.85; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS044
NP, Descending, 257236324323_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.12; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS044
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517471
sample_title: NP, Descending, 257236324323_2_4
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.12; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS044
NP, Sigmoid, 257236324324_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.12; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Sigmoid; patient_id: AS027
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517472
sample_title: NP, Sigmoid, 257236324324_1_1
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.12; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Sigmoid; patient_id: AS027
NP, Rectum, 257236324324_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.12; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS038
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517473
sample_title: NP, Rectum, 257236324324_1_2
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.12; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS038
P, Transverse, 257236324324_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 33; age_at_inclusion: 49; disease_duration_yr: 15.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Transverse; patient_id: AS041
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517474
sample_title: P, Transverse, 257236324324_1_4
source_name: Transverse
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 33; age_at_inclusion: 49; disease_duration_yr: 15.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Transverse; patient_id: AS041
P, Sigmoid, 257236324324_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 33; age_at_inclusion: 49; disease_duration_yr: 15.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Sigmoid; patient_id: AS041
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517475
sample_title: P, Sigmoid, 257236324324_2_2
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 33; age_at_inclusion: 49; disease_duration_yr: 15.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Sigmoid; patient_id: AS041
P, Rectum, 257236324324_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 33; age_at_inclusion: 49; disease_duration_yr: 15.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS041
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517476
sample_title: P, Rectum, 257236324324_2_4
source_name: Rectum
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 33; age_at_inclusion: 49; disease_duration_yr: 15.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: AS041
NP, Ascending, 257236327371_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 26; age_at_inclusion: 51; disease_duration_yr: 24.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: LC037
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517477
sample_title: NP, Ascending, 257236327371_1_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 26; age_at_inclusion: 51; disease_duration_yr: 24.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: LC037
NP, Descending, 257236327371_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 26; age_at_inclusion: 51; disease_duration_yr: 24.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: LC037
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517478
sample_title: NP, Descending, 257236327371_1_2
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 26; age_at_inclusion: 51; disease_duration_yr: 24.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: LC037
NP, Rectum, 257236327371_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 26; age_at_inclusion: 51; disease_duration_yr: 24.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: LC037
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517479
sample_title: NP, Rectum, 257236327371_1_3
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 26; age_at_inclusion: 51; disease_duration_yr: 24.93; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: LC037
NP, Ascending, 257236327371_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 19; age_at_inclusion: 31; disease_duration_yr: 12.34; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: LC040
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517480
sample_title: NP, Ascending, 257236327371_1_4
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 19; age_at_inclusion: 31; disease_duration_yr: 12.34; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: LC040
NP, Descending, 257236327371_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 19; age_at_inclusion: 31; disease_duration_yr: 12.34; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: LC040
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517481
sample_title: NP, Descending, 257236327371_2_1
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 19; age_at_inclusion: 31; disease_duration_yr: 12.34; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: LC040
NP, Rectum, 257236327371_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 19; age_at_inclusion: 31; disease_duration_yr: 12.34; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: LC040
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517482
sample_title: NP, Rectum, 257236327371_2_2
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 19; age_at_inclusion: 31; disease_duration_yr: 12.34; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: LC040
NP, Ascending, 257236327371_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 32; age_at_inclusion: 55; disease_duration_yr: 22.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: LC043
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517483
sample_title: NP, Ascending, 257236327371_2_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 32; age_at_inclusion: 55; disease_duration_yr: 22.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: LC043
NP, Descending, 257236327371_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 32; age_at_inclusion: 55; disease_duration_yr: 22.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: LC043
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517484
sample_title: NP, Descending, 257236327371_2_4
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 32; age_at_inclusion: 55; disease_duration_yr: 22.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: LC043
NP, Sigmoid, 257236327372_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 32; age_at_inclusion: 55; disease_duration_yr: 22.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Sigmoid; patient_id: LC003
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517485
sample_title: NP, Sigmoid, 257236327372_1_1
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 32; age_at_inclusion: 55; disease_duration_yr: 22.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Sigmoid; patient_id: LC003
NP, Rectum, 257236327372_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 54; age_at_inclusion: 74; disease_duration_yr: 19.82; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: LC003
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517486
sample_title: NP, Rectum, 257236327372_1_2
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 54; age_at_inclusion: 74; disease_duration_yr: 19.82; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Rectum; patient_id: LC003
P, Ascending, 257236327372_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 54; age_at_inclusion: 74; disease_duration_yr: 19.82; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: LC026
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517487
sample_title: P, Ascending, 257236327372_1_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 54; age_at_inclusion: 74; disease_duration_yr: 19.82; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: LC026
P, Transverse, 257236327372_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 54; age_at_inclusion: 74; disease_duration_yr: 19.82; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Transverse; patient_id: LC026
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517488
sample_title: P, Transverse, 257236327372_2_1
source_name: Transverse
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 54; age_at_inclusion: 74; disease_duration_yr: 19.82; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Transverse; patient_id: LC026
P, Descending, 257236327372_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 54; age_at_inclusion: 74; disease_duration_yr: 19.82; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: LC026
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517489
sample_title: P, Descending, 257236327372_2_2
source_name: Descending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 54; age_at_inclusion: 74; disease_duration_yr: 19.82; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: LC026
P, Sigmoid, 257236327372_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 75; disease_duration_yr: 42.23; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 1; tissue: Sigmoid; patient_id: LC026
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517490
sample_title: P, Sigmoid, 257236327372_2_3
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 75; disease_duration_yr: 42.23; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 1; tissue: Sigmoid; patient_id: LC026
P, Rectum, 257236327372_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 75; disease_duration_yr: 42.23; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 1; tissue: Rectum; patient_id: LC026
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517491
sample_title: P, Rectum, 257236327372_2_4
source_name: Rectum
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 75; disease_duration_yr: 42.23; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 1; tissue: Rectum; patient_id: LC026
NP, Ascending, 257236327373_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 75; disease_duration_yr: 42.23; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 1; tissue: Ascending; patient_id: AS098
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517492
sample_title: NP, Ascending, 257236327373_1_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 33; age_at_inclusion: 75; disease_duration_yr: 42.23; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 1; tissue: Ascending; patient_id: AS098
NP, Transverse, 257236327373_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 19; age_at_inclusion: 45; disease_duration_yr: 26.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS098
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517493
sample_title: NP, Transverse, 257236327373_1_2
source_name: Transverse
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 19; age_at_inclusion: 45; disease_duration_yr: 26.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS098
NP, Rectum, 257236327373_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 19; age_at_inclusion: 45; disease_duration_yr: 26.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS098
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517494
sample_title: NP, Rectum, 257236327373_1_3
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 19; age_at_inclusion: 45; disease_duration_yr: 26.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS098
NP, Ascending, 257236327373_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 19; age_at_inclusion: 45; disease_duration_yr: 26.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS101
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517495
sample_title: NP, Ascending, 257236327373_1_4
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 19; age_at_inclusion: 45; disease_duration_yr: 26.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS101
NP, Descending, 257236327373_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 29; age_at_inclusion: 39; disease_duration_yr: 9.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 0; tissue: Descending; patient_id: AS101
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517496
sample_title: NP, Descending, 257236327373_2_1
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 29; age_at_inclusion: 39; disease_duration_yr: 9.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 0; tissue: Descending; patient_id: AS101
NP, Ascending, 257236327373_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 29; age_at_inclusion: 39; disease_duration_yr: 9.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 0; tissue: Ascending; patient_id: LC003
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517497
sample_title: NP, Ascending, 257236327373_2_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 29; age_at_inclusion: 39; disease_duration_yr: 9.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 0; tissue: Ascending; patient_id: LC003
NP, Descending, 257236327373_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 29; age_at_inclusion: 39; disease_duration_yr: 9.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 0; tissue: Descending; patient_id: LC003
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517498
sample_title: NP, Descending, 257236327373_2_4
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 29; age_at_inclusion: 39; disease_duration_yr: 9.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 0; tissue: Descending; patient_id: LC003
NP, Rectum, 257236327377_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 29; age_at_inclusion: 39; disease_duration_yr: 9.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 0; tissue: Rectum; patient_id: AS101
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517499
sample_title: NP, Rectum, 257236327377_1_1
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 29; age_at_inclusion: 39; disease_duration_yr: 9.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 0; tissue: Rectum; patient_id: AS101
P, Transverse, 257236327377_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: M; age_at_diagnosis: 29; age_at_inclusion: 39; disease_duration_yr: 9.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 0; tissue: Transverse; patient_id: LC052
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517500
sample_title: P, Transverse, 257236327377_1_3
source_name: Transverse
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: M; age_at_diagnosis: 29; age_at_inclusion: 39; disease_duration_yr: 9.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 1; other_medications: 0; tissue: Transverse; patient_id: LC052
P, Descending, 257236327377_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 22; age_at_inclusion: 50; disease_duration_yr: 27.53; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC052
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517501
sample_title: P, Descending, 257236327377_2_1
source_name: Descending
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 22; age_at_inclusion: 50; disease_duration_yr: 27.53; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC052
NP, Ascending, 257236327377_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 22; age_at_inclusion: 50; disease_duration_yr: 27.53; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC053
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517502
sample_title: NP, Ascending, 257236327377_2_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 22; age_at_inclusion: 50; disease_duration_yr: 27.53; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC053
NP, Ascending, 257236327377_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 22; age_at_inclusion: 50; disease_duration_yr: 27.53; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC067
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517503
sample_title: NP, Ascending, 257236327377_2_4
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 22; age_at_inclusion: 50; disease_duration_yr: 27.53; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC067
P, Ascending, 257236327378_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 51; age_at_inclusion: 72; disease_duration_yr: 20.55; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC093
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517504
sample_title: P, Ascending, 257236327378_1_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 51; age_at_inclusion: 72; disease_duration_yr: 20.55; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC093
P, Transverse, 257236327378_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 51; age_at_inclusion: 72; disease_duration_yr: 20.55; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: LC093
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517505
sample_title: P, Transverse, 257236327378_1_4
source_name: Transverse
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 51; age_at_inclusion: 72; disease_duration_yr: 20.55; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: LC093
P, Descending, 257236327378_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 51; age_at_inclusion: 72; disease_duration_yr: 20.55; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC093
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517506
sample_title: P, Descending, 257236327378_2_1
source_name: Descending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 51; age_at_inclusion: 72; disease_duration_yr: 20.55; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC093
P, Ascending, 257236327378_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: M; age_at_diagnosis: 51; age_at_inclusion: 72; disease_duration_yr: 20.55; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS041
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517507
sample_title: P, Ascending, 257236327378_2_2
source_name: Ascending
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: M; age_at_diagnosis: 51; age_at_inclusion: 72; disease_duration_yr: 20.55; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS041
P, Descending, 257236327378_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: M; age_at_diagnosis: 53; age_at_inclusion: 62; disease_duration_yr: 8.55; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS041
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517508
sample_title: P, Descending, 257236327378_2_3
source_name: Descending
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: M; age_at_diagnosis: 53; age_at_inclusion: 62; disease_duration_yr: 8.55; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS041
NP, Sigmoid, 257236327378_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 53; age_at_inclusion: 62; disease_duration_yr: 8.55; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: AS061
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517509
sample_title: NP, Sigmoid, 257236327378_2_4
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 53; age_at_inclusion: 62; disease_duration_yr: 8.55; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: AS061
NP, Sigmoid, 257236327379_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 41; age_at_inclusion: 61; disease_duration_yr: 20.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: LC067
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517510
sample_title: NP, Sigmoid, 257236327379_1_1
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 41; age_at_inclusion: 61; disease_duration_yr: 20.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: LC067
NP, Rectum, 257236327379_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 41; age_at_inclusion: 61; disease_duration_yr: 20.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC067
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517511
sample_title: NP, Rectum, 257236327379_1_2
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 41; age_at_inclusion: 61; disease_duration_yr: 20.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC067
NP, Ascending, 257236327379_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 41; age_at_inclusion: 61; disease_duration_yr: 20.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC076
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517512
sample_title: NP, Ascending, 257236327379_1_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 41; age_at_inclusion: 61; disease_duration_yr: 20.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC076
NP, Descending, 257236327379_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 41; age_at_inclusion: 61; disease_duration_yr: 20.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC076
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517513
sample_title: NP, Descending, 257236327379_1_4
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 41; age_at_inclusion: 61; disease_duration_yr: 20.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC076
NP, Sigmoid, 257236327379_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 22; age_at_inclusion: 44; disease_duration_yr: 21.66; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: LC076
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517514
sample_title: NP, Sigmoid, 257236327379_2_1
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic; gender: M; age_at_diagnosis: 22; age_at_inclusion: 44; disease_duration_yr: 21.66; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: LC076
NP, Ascending, 257236327379_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 44; disease_duration_yr: 21.66; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC078
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517515
sample_title: NP, Ascending, 257236327379_2_2
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 44; disease_duration_yr: 21.66; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC078
NP, Descending, 257236327379_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 44; disease_duration_yr: 21.66; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC078
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517516
sample_title: NP, Descending, 257236327379_2_3
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 44; disease_duration_yr: 21.66; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC078
NP, Ascending, 257236327383_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 44; disease_duration_yr: 21.66; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC053
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517517
sample_title: NP, Ascending, 257236327383_1_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 44; disease_duration_yr: 21.66; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC053
NP, Descending, 257236327383_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 44; disease_duration_yr: 21.66; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC053
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517518
sample_title: NP, Descending, 257236327383_1_2
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 44; disease_duration_yr: 21.66; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC053
NP, Sigmoid, 257236327383_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 18; age_at_inclusion: 36; disease_duration_yr: 17.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: LC053
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517519
sample_title: NP, Sigmoid, 257236327383_1_3
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 18; age_at_inclusion: 36; disease_duration_yr: 17.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: LC053
NP, Rectum, 257236327383_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 18; age_at_inclusion: 36; disease_duration_yr: 17.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC053
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517520
sample_title: NP, Rectum, 257236327383_1_4
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 18; age_at_inclusion: 36; disease_duration_yr: 17.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC053
NP, Ascending, 257236327383_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: F; age_at_diagnosis: 18; age_at_inclusion: 36; disease_duration_yr: 17.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC054
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517521
sample_title: NP, Ascending, 257236327383_2_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: F; age_at_diagnosis: 18; age_at_inclusion: 36; disease_duration_yr: 17.94; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC054
NP, Descending, 257236327383_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 24; age_at_inclusion: 35; disease_duration_yr: 10.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC054
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517522
sample_title: NP, Descending, 257236327383_2_2
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 24; age_at_inclusion: 35; disease_duration_yr: 10.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC054
NP, Rectum, 257236327383_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 24; age_at_inclusion: 35; disease_duration_yr: 10.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC054
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517523
sample_title: NP, Rectum, 257236327383_2_3
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 24; age_at_inclusion: 35; disease_duration_yr: 10.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC054
P, Transverse, 257236327384_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 24; age_at_inclusion: 35; disease_duration_yr: 10.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: LC052
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517524
sample_title: P, Transverse, 257236327384_1_3
source_name: Transverse
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 24; age_at_inclusion: 35; disease_duration_yr: 10.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: LC052
P, Sigmoid, 257236327384_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: F; age_at_diagnosis: 19; age_at_inclusion: 69; disease_duration_yr: 49.48; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: LC052
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517525
sample_title: P, Sigmoid, 257236327384_2_2
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: F; age_at_diagnosis: 19; age_at_inclusion: 69; disease_duration_yr: 49.48; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: LC052
NP, Rectum, 257236327385_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 19; age_at_inclusion: 69; disease_duration_yr: 49.48; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC043
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517526
sample_title: NP, Rectum, 257236327385_1_1
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 19; age_at_inclusion: 69; disease_duration_yr: 49.48; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC043
NP, Ascending, 257236327385_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 19; age_at_inclusion: 69; disease_duration_yr: 49.48; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC046
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517527
sample_title: NP, Ascending, 257236327385_1_2
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 19; age_at_inclusion: 69; disease_duration_yr: 49.48; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC046
NP, Descending, 257236327385_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.78; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC046
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517528
sample_title: NP, Descending, 257236327385_1_3
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: F; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.78; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC046
NP, Rectum, 257236327385_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: F; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.78; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC046
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517529
sample_title: NP, Rectum, 257236327385_1_4
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: F; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.78; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC046
NP, Ascending, 257236327385_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: F; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.78; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC049
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517530
sample_title: NP, Ascending, 257236327385_2_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: Chronic_active; gender: F; age_at_diagnosis: 48; age_at_inclusion: 61; disease_duration_yr: 12.78; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC049
NP, Descending, 257236327385_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 34; age_at_inclusion: 44; disease_duration_yr: 10.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC049
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517531
sample_title: NP, Descending, 257236327385_2_2
source_name: Descending
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 34; age_at_inclusion: 44; disease_duration_yr: 10.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: LC049
NP, Rectum, 257236327385_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 34; age_at_inclusion: 44; disease_duration_yr: 10.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC049
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517532
sample_title: NP, Rectum, 257236327385_2_3
source_name: Rectum
characteristics: disease state: UC; progressor_status: NP; inflammation_status: None; gender: M; age_at_diagnosis: 34; age_at_inclusion: 44; disease_duration_yr: 10.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: LC049
P, Ascending, 257236327385_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 34; age_at_inclusion: 44; disease_duration_yr: 10.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC052
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517533
sample_title: P, Ascending, 257236327385_2_4
source_name: Ascending
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 34; age_at_inclusion: 44; disease_duration_yr: 10.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: LC052
P, Transverse, 257236334423_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 29; age_at_inclusion: 66; disease_duration_yr: 36.61; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS275
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517534
sample_title: P, Transverse, 257236334423_1_1
source_name: Transverse
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 29; age_at_inclusion: 66; disease_duration_yr: 36.61; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS275
P, Descending, 257236334423_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 29; age_at_inclusion: 66; disease_duration_yr: 36.61; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS275
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517535
sample_title: P, Descending, 257236334423_1_2
source_name: Descending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 29; age_at_inclusion: 66; disease_duration_yr: 36.61; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS275
P, Ascending, 257236334423_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 29; age_at_inclusion: 66; disease_duration_yr: 36.61; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS329
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517536
sample_title: P, Ascending, 257236334423_1_3
source_name: Ascending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 29; age_at_inclusion: 66; disease_duration_yr: 36.61; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS329
P, Descending, 257236334423_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 29; age_at_inclusion: 66; disease_duration_yr: 36.61; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS329
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517537
sample_title: P, Descending, 257236334423_1_4
source_name: Descending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 29; age_at_inclusion: 66; disease_duration_yr: 36.61; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS329
P, Ascending, 257236334423_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 29; age_at_inclusion: 66; disease_duration_yr: 36.61; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS327
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517538
sample_title: P, Ascending, 257236334423_2_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 29; age_at_inclusion: 66; disease_duration_yr: 36.61; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS327
P, Descending, 257236334423_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 30; disease_duration_yr: 8.06; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS327
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517539
sample_title: P, Descending, 257236334423_2_2
source_name: Descending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 30; disease_duration_yr: 8.06; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS327
P, Sigmoid, 257236334423_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 30; disease_duration_yr: 8.06; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: AS327
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517540
sample_title: P, Sigmoid, 257236334423_2_3
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 30; disease_duration_yr: 8.06; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: AS327
P, Rectum, 257236334423_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 22; age_at_inclusion: 30; disease_duration_yr: 8.06; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS327
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517541
sample_title: P, Rectum, 257236334423_2_4
source_name: Rectum
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 22; age_at_inclusion: 30; disease_duration_yr: 8.06; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS327
P, Ascending, 257236334424_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 30; disease_duration_yr: 8.06; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS208
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517542
sample_title: P, Ascending, 257236334424_1_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 30; disease_duration_yr: 8.06; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS208
P, Transverse, 257236334424_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 30; disease_duration_yr: 8.06; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS208
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517543
sample_title: P, Transverse, 257236334424_1_2
source_name: Transverse
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 22; age_at_inclusion: 30; disease_duration_yr: 8.06; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS208
P, Descending, 257236334424_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: M; age_at_diagnosis: 29; age_at_inclusion: 68; disease_duration_yr: 38.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS208
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517544
sample_title: P, Descending, 257236334424_1_3
source_name: Descending
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: M; age_at_diagnosis: 29; age_at_inclusion: 68; disease_duration_yr: 38.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS208
P, Rectum, 257236334424_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 29; age_at_inclusion: 68; disease_duration_yr: 38.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS208
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517545
sample_title: P, Rectum, 257236334424_1_4
source_name: Rectum
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 29; age_at_inclusion: 68; disease_duration_yr: 38.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS208
P, Ascending, 257236334424_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 29; age_at_inclusion: 68; disease_duration_yr: 38.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS250
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517546
sample_title: P, Ascending, 257236334424_2_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 29; age_at_inclusion: 68; disease_duration_yr: 38.68; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS250
P, Descending, 257236334424_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 45; disease_duration_yr: 19.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS250
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517547
sample_title: P, Descending, 257236334424_2_2
source_name: Descending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 45; disease_duration_yr: 19.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Descending; patient_id: AS250
P, Sigmoid, 257236334424_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 45; disease_duration_yr: 19.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Sigmoid; patient_id: AS250
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517548
sample_title: P, Sigmoid, 257236334424_2_3
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 45; disease_duration_yr: 19.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Sigmoid; patient_id: AS250
P, Ascending, 257236334424_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 45; disease_duration_yr: 19.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS275
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517549
sample_title: P, Ascending, 257236334424_2_4
source_name: Ascending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: F; age_at_diagnosis: 26; age_at_inclusion: 45; disease_duration_yr: 19.31; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 1; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 1; tissue: Ascending; patient_id: AS275
P, Ascending, 257236334425_1_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: M; age_at_diagnosis: 25; age_at_inclusion: 38; disease_duration_yr: 13.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS318
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517550
sample_title: P, Ascending, 257236334425_1_1
source_name: Ascending
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: M; age_at_diagnosis: 25; age_at_inclusion: 38; disease_duration_yr: 13.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS318
P, Transverse, 257236334425_1_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 25; age_at_inclusion: 38; disease_duration_yr: 13.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS318
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517551
sample_title: P, Transverse, 257236334425_1_2
source_name: Transverse
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 25; age_at_inclusion: 38; disease_duration_yr: 13.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS318
P, Descending, 257236334425_1_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Descending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 25; age_at_inclusion: 38; disease_duration_yr: 13.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS318
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517552
sample_title: P, Descending, 257236334425_1_3
source_name: Descending
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 25; age_at_inclusion: 38; disease_duration_yr: 13.46; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Descending; patient_id: AS318
P, Sigmoid, 257236334425_1_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: F; age_at_diagnosis: 23; age_at_inclusion: 38; disease_duration_yr: 14.83; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: AS318
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517553
sample_title: P, Sigmoid, 257236334425_1_4
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: F; age_at_diagnosis: 23; age_at_inclusion: 38; disease_duration_yr: 14.83; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: AS318
P, Rectum, 257236334425_2_1
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Rectum
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: F; age_at_diagnosis: 23; age_at_inclusion: 38; disease_duration_yr: 14.83; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS318
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517554
sample_title: P, Rectum, 257236334425_2_1
source_name: Rectum
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic; gender: F; age_at_diagnosis: 23; age_at_inclusion: 38; disease_duration_yr: 14.83; salazopyrine: 0; x5_asa: 1; azathioprine_metotrexate: 0; infliximab: 0; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Rectum; patient_id: AS318
P, Ascending, 257236334425_2_2
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Ascending
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 17; age_at_inclusion: 33; disease_duration_yr: 16.38; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS324
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517555
sample_title: P, Ascending, 257236334425_2_2
source_name: Ascending
characteristics: disease state: UC; progressor_status: P; inflammation_status: Chronic_active; gender: M; age_at_diagnosis: 17; age_at_inclusion: 33; disease_duration_yr: 16.38; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Ascending; patient_id: AS324
P, Transverse, 257236334425_2_3
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Transverse
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 17; age_at_inclusion: 33; disease_duration_yr: 16.38; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS324
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517556
sample_title: P, Transverse, 257236334425_2_3
source_name: Transverse
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 17; age_at_inclusion: 33; disease_duration_yr: 16.38; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Transverse; patient_id: AS324
P, Sigmoid, 257236334425_2_4
Not included: the study role or selected requirements have incomplete or conflicting evidence. organism: Homo sapiens — Insufficient evidence. assay type: bulk RNA-seq — Insufficient evidence. specimen category: Tissue or biopsy — Insufficient evidence. Study role: Case marker detected.
Requirements and decision evidence
-
organism: Homo sapiens — Insufficient evidence
- The required value is not reported.
-
assay type: bulk RNA-seq — Insufficient evidence
- The required value is not reported.
-
specimen category: Tissue or biopsy — Insufficient evidence
- The required value is not reported.
-
excluded sample type excludes: cell line, organoid, xenograft — Meets requirement
- Supported by the indexed evidence.
-
specimen category excludes: Biofluid — Meets requirement
- Supported by the indexed evidence.
Source metadata
- Source name
- Sigmoid
- Characteristics
- disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 17; age_at_inclusion: 33; disease_duration_yr: 16.38; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: AS324
- Description
- Not reported
- Indexed organism evidence
- INFERRED · PARENT_INHERITED: Not reported
- Indexed assay evidence
- INFERRED · PARENT_INHERITED: Not reported
- Source
- GEO
Original indexed metadata
sample_accession: GSM7517557
sample_title: P, Sigmoid, 257236334425_2_4
source_name: Sigmoid
characteristics: disease state: UC; progressor_status: P; inflammation_status: None; gender: M; age_at_diagnosis: 17; age_at_inclusion: 33; disease_duration_yr: 16.38; salazopyrine: 0; x5_asa: 0; azathioprine_metotrexate: 1; infliximab: 1; adalimumab: 0; vedolizumab: 0; other_medications: 0; tissue: Sigmoid; patient_id: AS324